Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: Prospective cohort study

BMJ

Volumn 342, Issue 7806, 2011, Pages

  Chen, Yu ^a   Graziano, Joseph H ^b   Parvez, Faruque ^b   Liu, Mengling ^a   Slavkovich, Vesna ^b   Kalra, Tara ^c   Argos, Maria ^c   Islam, Tariqul ^c   Ahmed, Alauddin ^c   Rakibuz Zaman, Muhammad ^c   Hasan, Rabiul ^c   Sarwar, Golam ^c   Levy, Diane ^b   Van Geen, Alexander ^d   Ahsan, Habibul ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d Department of Earth and Environmental Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER; WELL WATER;

ADULT; AGED; ARTICLE; BANGLADESH; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FEMALE; HAZARD RATIO; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; URINALYSIS; WATER ANALYSIS; ADOLESCENT; ARSENIC POISONING; CAUSE OF DEATH; CHEMICALLY INDUCED DISORDER; FOOD ANALYSIS; HEART DISEASE; MIDDLE AGED; SMOKING; WATER POLLUTANT; WATER SUPPLY;

ADOLESCENT; ADULT; AGED; ARSENIC; ARSENIC POISONING; BANGLADESH; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOOD ANALYSIS; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY; YOUNG ADULT;

EID: 79955954693     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2431     Document Type: Article

References (71)

1. United States Environmental Protection Agency. Fact sheet: drinking water standard for arsenic. EPA 815-F-00-015. 2009. www.epa.gov/safewater/arsenic/ regulations-factsheet.html.
2. Wang CH, Hsiao CK, Chen CL, Hsu LI, Chiou HY, Chen SY,et al. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol 2007;222:315-26.
3. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005;162:1037-49. (Pubitemid 41746616)
4. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995;25:53-60.
5. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension 1999;33:74-8. (Pubitemid 29061844)
6. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between ischemic heart diseasemortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 1996;16:504-10.
7. Tseng CH, Chong CK, Tseng CP, Hsueh YM, Chiou HY, Tseng CC, et al. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett 2003;137:15-21.
8. Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsueh YM, et al. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 2002;105:1804-9.
9. Tseng CH, Chong CK, Chen CJ, Tai TY. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 1996;120:125-33.
10. Hsueh YM, Wu WL, Huang YL, Chiou HY, Tseng CH, Chen CJ. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 1998;141:249-57.
11. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, et al. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 2007;166:1381-91.
12. Engel RR, Smith AH. Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health 1994;49:418-27. (Pubitemid 24322178)
13. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 1999;107:359-65. (Pubitemid 29405841)
14. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 2007;6:4.
15. Medrano MA, Boix R, Pastor-Barriuso R, Palau M, Damian J, Ramis R, et al. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res 2010;110:448-54.
16. Chen Y, Graziano JH, Parvez F, Hussain I, Momotaj H, van Geen A, et al. Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology 2006;17:459-67. (Pubitemid 44305520)
17. Lindberg AL, Sohel N, Rahman M, Persson LA, Vahter M. Impact of smoking and chewing tobacco on arsenic-induced skin lesions. Environ Health Perspect 2010;118:533-8.
18. Steinmaus C, Yuan Y, Bates MN, Smith AH. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 2003;158:1193-201. (Pubitemid 37548789)
19. Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, et al. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 2004;15:465-72. (Pubitemid 39060938)
20. Chen CL, Hsu LI, Chiou HY, Hsueh YM, Chen SY, Wu MM, et al. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA 2004;292:2984-90.
21. Chowdhury UK, Biswas BK, Chowdhury TR, Samanta G, Mandal BK, Basu GC, et al. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect 2000;108:393-7. (Pubitemid 30421015)
22. Mudur G. Half of Bangladesh population at risk of arsenic poisoning. BMJ 2000;320:822.
23. British Geological Survey. Groundwater studies for arsenic contamination in Bangladesh - phase 1 findings. 1999. www.bgs.ac.uk/arsenic/.
24. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, et al. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol 2006;16:191-205.
25. Parvez F, Chen Y, Argos M, Hussain AZ, Momotaj H, Dhar R, et al. Prevalence of arsenic exposure from drinking water and awareness of its health risks in a Bangladeshi population: results from a large population-based study. Environ Health Perspect 2006;114:355-9. (Pubitemid 43338259)
26. Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt-Rauf P, Parvez F, et al. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am J Epidemiol 2007;165:541-52. (Pubitemid 46340549)
27. Chen, Y, Ahsan H, Slavkovich V, Peltier GL, Gluskin RT, Parvez F, et al. No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh: Environ Health Perspect 2010;118:1299-305.
28. Pierce BL, Kalra T, Argos M, Parvez F, Chen Y, Islam T, et al. A prospective study of body mass index and mortality in Bangladesh. Int J Epidemiol 2010;39:1037-45.
29. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980;58:113-30. (Pubitemid 10013261)
30. World Health Organization. Manual of the international classification of diseases, injuries and causes of death. WHO, 2007.
31. Ronsmans C, Vanneste AM, Chakraborty J, Van Ginneken J. A comparison of three verbal autopsy methods to ascertain levels and causes of maternal deaths in Matlab, Bangladesh. Int J Epidemiol 1998;27:660-6. (Pubitemid 28431510)
32. Baqui AH, Black RE, Arifeen SE, Hill K, Mitra SN, al Sabir A. Causes of childhood deaths in Bangladesh: results of a nationwide verbal autopsy study. Bull World Health Organ 1998;76:161-71.
33. Sohel N, Persson LA, Rahman M, Streatfield PK, Yunus M, Ekstrom EC, et al. Arsenic in drinking water and adult mortality: a population-based cohort study in rural Bangladesh. Epidemiology 2009;20:824-30.
34. Van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, Hussain I, et al. Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull World Health Organ 2002;80:732-7.
35. 2 area of Bangladesh. Water Resour Res 2003;39:1140.
36. Cheng Z, van Geen A, Seddique AA, Ahmed KM. Limited temporal variability of arsenic concentrations in 20 wells monitored for 3 years in Araihazar, Bangladesh. Environ Sci Technol 2005;39:4759-66. (Pubitemid 40966700)
37. Cheng Z, Zheng Y, Mortlock R, van Geen A. Rapid multi-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry. Anal Bioanal Chem 2004;379:512-8. (Pubitemid 40877580)
38. Ahsan H, Chen Y, Parvez F, Zablotska L, Argos M, Hussain I, et al. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am J Epidemiol 2006;163:1138-48. (Pubitemid 43987578)
39. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 1991;37:1575-9. (Pubitemid 21905220)
40. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965;17:381-7.
41. Chen Y, van Geen A, Graziano JH, Pfaff A, Madajewicz M, Parvez F, et al. Reduction in urinary arsenic levels in response to arsenic mitigation efforts in Araihazar, Bangladesh. Environ Health Perspect 2007;115:917-23. (Pubitemid 46902247)
42. Chen Y, Ahsan H, Parvez F, Howe GR. Validity of a food-frequency questionnaire for a large prospective cohort study in Bangladesh. Br J Nutr 2004;92:851-9. (Pubitemid 39562165)
43. Argos M, Parvez F, Chen Y, Hussain AZ, Momotaj H, Howe GR, et al. Socioeconomic status and risk for arsenic-related skin lesions in Bangladesh. Am J Public Health 2007;97:825-31. (Pubitemid 47280127)
44. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-14. (Pubitemid 16207356)
45. Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt-Rauf P, Parvez F, et al. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am J Epidemiol 2007;165:541-52. (Pubitemid 46340549)
46. Tseng CH, Tai TY, Chong CK, Tseng CP, Lai MS, Lin BJ, et al. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 2000;108:847-51.
47. Gamble MV, Liu X. Urinary creatinine and arsenic metabolism. Environ Health Perspect 2005;113:A442-3.
48. Steinmaus C, Yuan Y, Liaw J, Smith AH. On arsenic, diabetes, creatinine, and multiple regression modeling. Epidemiology 2009;20:e1-2.
49. Melkonian S, Argos M, Pierce BL, Chen Y, Islam T, Ahmed A, et al. A prospective study of the synergistic effects of arsenic exposure and smoking, sun exposure, fertilizer use, and pesticide use on risk of premalignant skin lesions in Bangladeshi men. Am J Epidemiol 2011;173:183-91.
50. Rothman KJ, Greenland S. Modern epidemiology. Little, Brown, 1986.
51. Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol 2007;17:227-36.
52. Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol 2007;36:1111-8. (Pubitemid 350018555)
53. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
54. Wei L, Lin D, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-73.
55. Greenland S, Robins J. Invited commentary: ecologic studies - biases, misconceptions, and counterexamples. Am J Epidemiol 1994;139:747-60.
56. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989;130:1123-32.
57. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 1997;28:1717-23.
58. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 2000;11:673-9.
59. Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 1996;104:620-8. (Pubitemid 26245412)
60. Bunderson M, Brooks DM, Walker DL, Rosenfeld ME, Coffin JD, Beall HD. Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol Appl Pharmacol 2004;201:32-9. (Pubitemid 39446324)
61. Simeonova PP, Hulderman T, Harki D, Luster MI. Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. Environ Health Perspect 2003;111:1744-8. (Pubitemid 37407934)
62. Srivastava S, Vladykovskaya EN, Haberzettl P, Sithu SD, D'Souza SE, States JC. Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice. Toxicol Appl Pharmacol 2009;241:90-100.
63. Simeonova PP, Luster MI. Arsenic and atherosclerosis. Toxicol Appl Pharmacol 2004;198:444-9. (Pubitemid 38969974)
64. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109:II2-10.
65. Dart AM, Kingwell BA. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001;37:975-84. (Pubitemid 32217593)
66. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003;107:2864-9. (Pubitemid 36705999)
67. Bunderson M, Coffin JD, Beall HD. Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: possible role in atherosclerosis. Toxicol Appl Pharmacol 2002;184:11-8. (Pubitemid 35264666)
68. Straub AC, Klei LR, Stolz DB, Barchowsky A. Arsenic requires sphingosine-1-phosphate type 1 receptors to induce angiogenic genes and endothelial cell remodeling. Am J Pathol 2009;174:1949-58.
69. Chen Y, Santella RM, Kibriya MG, Wang Q, Kappil M, Verret WJ, et al. Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules. Environ Health Perspect 2007;115:1415-20. (Pubitemid 47618082)
70. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, et al. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 2007;16:1270-8. (Pubitemid 46984970)
71. Tseng CH, Chong CK, Chen CJ, Tai TY. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology 1997;48:321-35.